FAKTOR-OPTIONSSCHEIN - AMGEN | Delayed Deutsche Boerse AG 11:45:23 2024-05-23 am EDT | ||
| 0.001 EUR | 0.00% |
|
| 1 month | -99.68% | ||
| 3 months | -99.60% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-05-23 | 0.001 | 0.00% |
| 24-05-22 | 0.001 | 0.00% |
| 24-05-21 | 0.001 | 0.00% |
| 24-05-20 | 0.001 | 0.00% |
| 24-05-17 | 0.001 | 0.00% |
Delayed Quote Deutsche Boerse AG
Last update May 23, 2024 at 11:45 am EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SQ6CGQ |
| ISIN | DE000SQ6CGQ5 |
| Date issued | 2022-12-14 |
| Strike | 276.6 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.27 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 42.19 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
